The largest database of trusted experimental protocols
> Procedures > Laboratory Procedure > Enzyme Assays

Enzyme Assays

Enzyme Assays: A powerful tool for analyzing enzyme activity and optimizing experimental protocols.
Leverage AI-driven comparisons to identify the best-performing methods from scientific literature, preprints, and patents.
Enhance reproducibility and research accuracy by selecting the most reliable protocols and products.
Streamline your workflow and deliver trustworthy results with PubCompare.ai's data-driven approach to enzyme assay optimization.
Experienece the benefits of this innovative platform today!

Most cited protocols related to «Enzyme Assays»

For determination of steady state labeling of polar metabolites, cells were cultured for approximately 24 hours in the presence of 13C-labeled glutamine or glucose before extraction. For experiments involving stable isotopic labeling of lipid biomass, cells were grown for approximately 3 – 4 days in the presence of tracer before extraction. Details of the extraction and derivatization methods are described in Supplementary Methods. Computational determination of metabolic fluxes, confidence intervals, de novo lipogenesis, and the contribution of tracers to fatty acid carbon was accomplished using an in-house software package, Metran19 (link). Details of the metabolic networks and GC/MS measurements used for modeling and complete results are described as Supplementary Information. The generation of cells stably expressing control shRNAs or those targeted IDH1 or IDH2 is described in Supplementary Methods; all experiments were conducted within 4 passages of initial selection. Hypoxic microenvironments were generated by feeding incubators with a pre-mixed gas composed of 1% O2, 5% CO2, and 94% N2, and O2 levels were confirmed to range between 1 and 3% using a Fyrite combustion analyzer. For details regarding recombinant IDH1 production and enzyme assays, T cell activation, medium analysis, [5-14C]glutamine experiment, and western blotting please see Supplementary Methods.
Publication 2011
Carbon Enzyme Assays Fatty Acids Gas Chromatography-Mass Spectrometry Glucose Glutamine Hypoxia IDH2, human Lipids Lipogenesis Metabolic Networks Short Hairpin RNA T-Lymphocyte
The oxygen reactivity of PMOs was measured by a time resolved quantification of H2O2 formation in 96-well plates (total volume of 200 μL) using a Perkin Elmer EnSpire Multimode plate reader. All reactions were performed in 100 mM sodium phosphate buffer, pH 6.0 at 22°C. Based on preliminary studies ascorbate and CDH were used in concentrations of 30 μM and 0.3 μM (0.025 mg mL-1), respectively to prevent a limitation in the PMO reduction step. As electron donor for CDH 500 μM cellobiose was used. When ascorbate was used as reductant, it was added to a final concentration of 30 μM and enzyme assays were started by mixing 20 μL of the respective PMO with 180 μL of the ready-made assay solution containing 30 μM ascorbate, 50 μM Amplex Red and 7.14 U mL-1 peroxidase in 96-well plate wells. In reference experiments without PMO the background signal (H2O2 production by CDH) was measured and subtracted from the assays. When CDH was used as reductant, the PMO assays were started by mixing 20 μL of sample solution and 20 μL CDH solution with 160 μL of the reaction mix containing cellobiose, Amplex Red and peroxidase. Initial fluorescence scans of resorufin showed highest signal intensities and lowest interference with matrix compounds when using an excitation wavelength of 569 nm and an emission wavelength of 585 nm for the selected conditions. The stoichiometry of H2O2 conversion to resorufin formation is 1:1. By using a high concentration of Amplex Red (50 μM) the linearity of the detection reaction was ensured and the molar ratio of Amplex Red:H2O2 was always greater than 50:1
[22 (link)]. The H2O2 concentration in the assays was far below 1 μM, which leads to a linear concentration/activity response of horseradish peroxidase, which has a KM for H2O2 of 1.55 μM. The high final activity of horseradish peroxidase (7.14 U mL-1) assures a fast conversion of the formed H2O2 and prevents the final reaction to be rate limiting. Additionally, it prevents the accumulation of H2O2, which could have detrimental effects on enzyme stability in the assay. The stability of resorufin fluorescence under these conditions was tested by addition of varying concentrations of hydrogen peroxide (0.1 – 5 μM) to the assay. A stable signal that remained constant throughout the measured period of 45 minutes was observed and maximum signal intensity was reached already during the mixing period before starting the assay. A linear relation between fluorescence and H2O2 concentrations in the range of 0.1 – 2 μM H2O2 was observed and the slope (28450 counts μmol-1) was used for the calculation of an enzyme factor to convert the fluorimeters readout (counts min-1), into enzyme activity. PMO activity was defined as one μmol H2O2 generated per minute under the defined assay conditions.
Full text: Click here
Publication 2012
Biological Assay Buffers Cellobiose Electrons enzyme activity Enzyme Assays Enzymes Enzyme Stability Fluorescence Horseradish Peroxidase Molar Oxygen Peroxidase Peroxide, Hydrogen Radionuclide Imaging Reducing Agents resorufin sodium phosphate Tissue Donors
The data set was prepared based on an extensive literature survey taking IC50 values of in-vitro enzyme inhibition assays against XO and HMGR by various secondary metabolites. Based on IC50 values, sixteen plant- and fungus-based secondary metabolites (Tables 1 and 2) were chosen for the ligand-protein docking study. The docking study was performed against commercial drugs such as atorvastatin, simvastatin, lovastatin, and pravastatin for HMGR. On the other hand, commercial drugs such as allopurinol, febuxostat, topiroxostat, and probenecid were used for molecular docking studies with XO. The structures of the ligand molecules and the control drugs of both enzymes were retrieved from the PubChem database [38 (link)] and verified from SciFinder. The structures were retrieved in SDF format and were converted to PDB and MOL2 format using Discovery Studio Visualizer 4.0 software. The structure and complete chemical properties, torsional energy, van der Waals potential energy, electrostatic energy, weight, log P, total polar surface area (TPSA), donor atoms, and acceptor atoms of the ligands were listed (Supplementary Table 4S) by the help of MOE Module [39 (link)].
Full text: Click here
Publication 2021
Allopurinol Atorvastatin chemical properties Electrostatics Enzyme Assays Enzymes Febuxostat Fungi Ligands Lovastatin Molecular Structure Pharmaceutical Preparations Plants Pravastatin Probenecid Proteins Psychological Inhibition Simvastatin Tissue Donors topiroxostat
All the patients enrolled on our Early Arthritis Clinic (EAC) register between September 2001 and November 2006 were considered in this study. During this period 190 patients were included, although only 171 patients completed the two year follow-up (the last patient ended in November 2008). Data from 638 visits corresponding to these later patients were considered for the analysis.
There were 14 patients lost to follow-up and 5 exitus. Deceased patients were significantly older, had a lower educational level and they also displayed a tendency towards a higher HAQ and DAS28 at baseline than those who finished the follow-up (Table S1). Patients lost to follow-up did not differ significantly from completers (Table S1).
Our EAC covers a population of 500,000 inhabitants, >90% of whom are attended by public health insurance. In addition, all primary care physicians in the area are aware of the EAC. To be referred to the clinic, patients must have two or more swollen joints for at least four weeks and symptoms for less than a year. Patients with other specific causes of arthritis were excluded. Thus, only data from patients that fulfilled the ACR criteria for the diagnosis of RA [35] (link) or with chronic undifferentiated arthritis were analyzed. When the 171 patients that fulfilled the two year follow-up were considered, 71% fulfilled the 1987 criteria for RA classification, while 29% remained as undifferentiated arthritis (UA: Table S2) at the end of the follow-up. These two subpopulations did not differ significantly except that the RA patients had a more severe disease at baseline and the educational level of the UA subpopulation was higher (Table S2).
The register's protocol included four visits during a follow up period of two years (baseline, 6, 12 and 24 months). At each visit, the following data were collected and entered into an electronic database: clinical and demographic information; disease duration at the beginning of the follow up; 28 tender and swollen joint counts (TJC and SJC, respectively); global disease activity on a 100 mm visual analogue scale assessed both by the patient (GDAP) and the physician (GDAPh); Spanish version of the Health Assessment Questionnaire [36] (link); and laboratory tests including erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and RF levels assessed by nephelometry (positive>20 UI/ml) and ACPA measured by enzyme immune assay (EIA) (Euro-Diagnostica Immunoscan RA; positive >50 UI/ml).
Full text: Click here
Publication 2011
Arthritis C Reactive Protein Diagnosis Enzyme Assays Health Insurance Hispanic or Latino Joints Nephelometry Patients Physicians Population Group Primary Care Physicians Sedimentation Rates, Erythrocyte Visual Analog Pain Scale

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2014
Ala-Trp-Arg-His-Pro-Gln-Phe-Gly-Gly Anabolism Anions APC protocol Biological Assay Buffers Catalysis Chromatography Chromatography, Affinity Co-Immunoprecipitation Crystallography Direct-On II Electron Microscopy Enzyme Assays Enzymes Gel Chromatography HEPES Homo sapiens Kinetics Proteins SDS-PAGE Sodium Chloride Tissue Donors Tween 20 Twins Ubiquitination Yeast, Dried

Most recents protocols related to «Enzyme Assays»

Example 5

Optimizing Inhibitor Cocktail to Maximize Buccal Sample Non-Specific Protease Activity Inhibition

29 inhibitors were tested using a competitive enzymatic activity assay of 3CL protease in buccal samples.

PMSF, GW, aprotinin, eglinC and pepstatin all decreased non-specific protease activity in saliva, with a non significant inhibition of 3CL specific activity.

The four best inhibitors were Eglin C, GW, PMSF and 2,6 PDA.

Various inhibitor cocktails were also tested:

    • Cocktail 1 (PMSF, GW);
    • Cocktail 2 (Eglin C, GW, PMSF and 2,6 PDA)
    • Cocktail 2 reduced non-specific proteases to a greater degree than cocktail 1.

Full text: Click here
Patent 2024
Aprotinin eglin C Endopeptidases Enzyme Assays inhibitors pepstatin Peptide Hydrolases Protease Inhibitors Psychological Inhibition SARS-CoV-2 Xerostomia

Example 12

The ability of these compounds to inhibit the NoV, specifically Minerva virus protease catalytic Cys139 covalently (IC50 and Ki) was determined with an enzyme kinetic assay. NoV strains, specifically GII.4 such as the Minerva virus are responsible for causing the majority (˜80%) of infections in humans. The activity of the inhibitors was evaluated by monitoring the cleavage of a FRET substrate every one minute for 20 minutes (excitation/emission: 488/520 nm) using a SpectraMax M5 microplate reader (Molecular Devices, Sunnyvale CA). Serial dilutions of each inhibitor were incubated with enzyme for 90 minutes at 37° C. before addition of the FRET substrate to ensure complete inactivation. Commercially available protease inhibitors chymostatin and rupintrivir were used as controls.

TABLE 4
CompoundIC50 (μM)Ki (μM)
110.112 ± 0.0250.427 ± 0.109
190.150 ± 0.002 1.19 ± 0.444
230.204 ± 0.009 1.59 ± 0.050
290.140 ± 0.0170.670 ± 0.019
350.167 ± 0.0050.858 ± 0.032
36 1.17 ± 0.333 3.60 ± 0.501
372.63 ± 1.0414.03 ± 5.55 
38>10ND
39>10ND
64>100ND
6730.0 ± 1.8 >100
830.482 ± 0.07 7.095 ± 5.583
84>100ND
chymostatin13.71.6 ± 1.0
rupintrivir23.68.2 ± 2.3

Full text: Click here
Patent 2024
Cardiac Arrest Catalysis chymostatin Cytokinesis Enzyme Assays Enzymes Fluorescence Resonance Energy Transfer Homo sapiens Infection inhibitors Kinetics Medical Devices Norovirus Infection Peptide Hydrolases Peptidomimetics Protease Inhibitors rupintrivir Strains Technique, Dilution Virus
GLA activities were determined in Fabry mouse tissues using previously described methods (Desnick et al., 1973 (link)). In brief, tissue samples were homogenized in chilled reporter lysis buffer (Promega) and protease inhibitor (Pierce) was added to the lysates. Protein concentrations were determined using the Bio-Rad Colorimetric Protein Assay Kit. 10 μL of tissue lysate was added to an equal volume of 10 mM 4-methylumbelliferyl-α-D-galactopyranoside (Sigma-Aldrich), dissolved in assay buffer (0.2 M citrate, 0.4 M phosphate buffer, pH 4.4), and 0.1 M N-acetylgalactosamine (Sigma Aldrich), the latter to inhibit α-galactosidase B activity (Mayes et al., 1981 (link)). Following a 30 min incubation at 37°C, reactions were terminated by the addition of 480 μL of 0.1 M ethylenediamine, pH 10.3. The amount of 4-methylumbelliferone (4-MU) produced was determined by measuring fluorescence using a Synergy H1 fluorometer (BioTek). Tissue α-Gal A activities were expressed as nmol of 4-MU produced per h per mg of total protein (nmol/h/mg). Measurement of plasma GLA activities in wildtype mice for PK studies was performed as described above with the following modifications: lysates were incubated with 5 mM 4-methylumbelliferyl α-D-galactopyranoside in assay buffer [20 mM citrate, 30 mM sodium phosphate (pH 4.4), 0.1 M N-acetylgalactosamine, and 4 mg/mL BSA], and the reaction was stopped by addition of stop buffer (0.1 M Glycine, 0.1 N NaOH], as previously described (Shen et al., 2016 (link)).
AGA activity was measured with 1 mM L-aspartic acid β-(7- amido-4-methylcoumarin) in 10% SuperBlock and 90% 50 mM Tris-HC (pH 7.5) for 60 min at 37°C, and then adding 100 µL of stop buffer [0.2 M glycine, 0.175 M NaOH (pH 10.6)], as previously described (Mononen et al., 1993 (link)). GUSB enzyme assay was performed using 10 mM 4-methylumbelliferyl-β-D-glucuronide (Merck) in 0.1 M sodium acetate (pH 4.6) at 37°C for 30 min, and reactions were stopped by 0.1 M sodium carbonate (Grubb et al., 2008 (link)). GAA activity assay was performed with 3 mM 4-methylumbelliferyl-a-D-glucopyranoside (Merck) in assay buffer (30 mM sodium citrate, 40 mM sodium phosphate dibasic, pH 4.0) at 37°C for 3 h (Flanagan et al., 2009 (link)). Reactions were stopped by the addition of an equal volume of 0.4 M glycine, pH 10.8. IDS activity assay was performed with 2.5 mM 4-Methylumbelliferyl sulfate potassium salt (Merck) in 50 mM sodium acetate, at 37°C for 4 h (Dean et al., 2006 (link)). Reactions were stopped with glycine carbonate buffer (pH 10.7). Fluorescence was measured by microplate reader with 360/40 nm excitation and 440/30 nm emission filters.
Full text: Click here
Publication 2023
4-benzaldehydesulfonic acid 4-methylumbelliferyl sulfate, potassium salt 7-methylcoumarin Acetylgalactosamine Aspartic Acid Biological Assay Buffers Carbonates Cardiac Arrest Citrates Colorimetry Enzyme Assays Ethylenediamines Exhaling Fluorescence Galactose Galactosidase Glucuronides Glycine Hymecromone Mice, House Phosphates Plasma Promega Protease Inhibitors Proteins RRAD protein, human Sodium Acetate sodium carbonate Sodium Citrate sodium phosphate Tissues Tromethamine
For transfection experiments, MC were plated at 50% confluency and transfected with either 1 µg of the mouse TSP1 luciferase reporter construct [mTSP1-luciferase, a gift from P. Bornstein, Plasmid #12409, Addgene (Michaud-Levesque and Richard, 2009 (link))] with 0.05 µg pCMV β-galactosidase (β-Gal, Clonetech) using Effectene (Qiagen) or 100 nM of MTJ1 or control siRNA (Silencer Select, ThermoFisher) using Lipofectamine (Invitrogen). After 18 h, cells were serum-deprived and treated as above for protein collection for siRNA experiments. For luciferase harvest, 1× Reporter Lysis Buffer (Promega) was added to the plate which was then stored at −80°C overnight prior to cell lysis. Luciferase activity was measured on clarified lysate using the Luciferase Assay System (Promega) with a luminometer (Junior LB 9509, Berthold). Β-Gal activity was used to normalize transfection efficiency, measured using the β-Galactosidase Enzyme Assay System (Promega) with a SpectraMax Plus 384 Microplate Reader (Molecular Devices) set to read absorbance at 420 nm.
The pcDNA3.1 plasmid which contains GRP78 lacking its ER retention sequence KDEL was transfected by electroporation as previously described (Trink et al., 2022 (link)). This was used to overexpress GRP78 at the cell surface. The empty vector pcDNA 3.1 was used as a control.
Full text: Click here
Publication 2023
beta-Galactosidase Biological Assay Buffers Cells Cloning Vectors Effectene Electroporation Enzyme Assays Glucose Regulated Protein 78 kDa Lipofectamine Luciferases Medical Devices Mus Plasmids Promega Proteins Retention (Psychology) RNA, Small Interfering Serum thrombospondin-1, human Transfection
Fasting venous blood samples were obtained within 2 weeks after stroke onset. Quantitative IDO1 assay was performed for the determination of IDO1 concentrations in serum using double-antibody sandwich enzyme-linked immune-sorbent assay kit provided by Shanghai Tianhao Biotechnology Co., Ltd., China. The minimum detectable dose was less than 0.1 ng/mL. The inter- and intra-assay coefficients of variation were less than 10% and 15%, respectively.
Full text: Click here
Publication 2023
Biological Assay Cerebrovascular Accident Enzyme Assays Immunoglobulins Serum Veins

Top products related to «Enzyme Assays»

Sourced in United States, Switzerland
The β-Galactosidase Enzyme Assay System is a laboratory equipment used to measure the activity of the enzyme β-galactosidase. The assay system provides a colorimetric method for quantifying β-galactosidase enzyme levels in samples.
Sourced in United States, United Kingdom, Germany, China, France, Japan, Canada, Netherlands, Mongolia, Switzerland, Australia
ELISA kits are laboratory tools used to detect and quantify specific proteins or other molecules in a sample. The kits utilize enzyme-linked immunosorbent assay (ELISA) technology to identify the target analyte. ELISA kits provide a standardized and reliable method for sample analysis.
Sourced in United Kingdom, United States, China
The Complex I Enzyme Activity Microplate Assay Kit is a laboratory equipment product that provides a method to measure the activity of the mitochondrial respiratory complex I. The kit includes a microplate, reagents, and necessary components to perform the assay.
Sourced in United States, Germany, United Kingdom, Australia, Switzerland, Japan, China, France, Sweden, Italy, Spain, Austria, Finland
The Luciferase Assay System is a laboratory tool designed to measure the activity of the luciferase enzyme. Luciferase is an enzyme that catalyzes a bioluminescent reaction, producing light. The Luciferase Assay System provides the necessary reagents to quantify the level of luciferase activity in samples, enabling researchers to study biological processes and gene expression.
Sourced in United States, United Kingdom, Germany, France, Mongolia, China, Canada, Switzerland, Sweden, Australia, Japan, Spain, Israel
ELISA (Enzyme-Linked Immunosorbent Assay) is a widely used analytical technique for the detection and quantification of specific proteins, hormones, antibodies, and other biomolecules in various samples. It is a plate-based assay that employs enzyme-linked antibodies to generate a measurable signal, typically in the form of a color change or a chemiluminescent reaction, which is proportional to the amount of the target analyte present in the sample.
Sourced in United States, Germany, United Kingdom, Israel, Canada, Austria, Belgium, Poland, Lao People's Democratic Republic, Japan, China, France, Brazil, New Zealand, Switzerland, Sweden, Australia
GraphPad Prism 5 is a data analysis and graphing software. It provides tools for data organization, statistical analysis, and visual representation of results.
Sourced in Switzerland, Germany, United States, France, Japan, Italy, China, United Kingdom, Sweden
The Cobas 8000 is a modular, automated in-vitro diagnostic system designed for high-throughput clinical chemistry and immunochemistry testing. It is used to perform a wide range of laboratory tests, including those for chemistry, immunoassay, and electrolyte analysis. The Cobas 8000 is capable of processing a large volume of samples efficiently and accurately.
Sourced in United States, United Kingdom, Canada, China, Germany, Japan, Belgium, Israel, Lao People's Democratic Republic, Italy, France, Austria, Sweden, Switzerland, Ireland, Finland
Prism 6 is a data analysis and graphing software developed by GraphPad. It provides tools for curve fitting, statistical analysis, and data visualization.
Sourced in Germany, United States, United Kingdom, Italy, Spain, Japan
The Immulite 2000 is an automated immunoassay analyzer designed for in vitro diagnostic testing. It is capable of performing a variety of immunoassay tests, including those for hormones, proteins, and other analytes. The system utilizes chemiluminescent technology for detection and provides automated sample handling, reagent management, and result reporting.
Sourced in United States, Austria, Canada, Belgium, United Kingdom, Germany, China, Japan, Poland, Israel, Switzerland, New Zealand, Australia, Spain, Sweden
Prism 8 is a data analysis and graphing software developed by GraphPad. It is designed for researchers to visualize, analyze, and present scientific data.

More about "Enzyme Assays"

Enzyme assays are a powerful tool for analyzing enzyme activity and optimizing experimental protocols.
These assays leverage AI-driven comparisons to identify the best-performing methods from scientific literature, preprints, and patents.
By enhancing reproducibility and research accuracy, enzyme assays enable researchers to select the most reliable protocols and products, streamlining their workflow and delivering trustworthy results.
The β-Galactosidase Enzyme Assay System is a commonly used assay for measuring the activity of the β-galactosidase enzyme, which is often used as a reporter gene in genetic studies.
ELISA (Enzyme-Linked Immunosorbent Assay) kits are another type of enzyme assay that are widely used for the quantitative measurement of various analytes, including proteins, hormones, and antibodies.
The Complex I Enzyme Activity Microplate Assay Kit is a specialized enzyme assay for measuring the activity of the mitochondrial Complex I enzyme, which is a key component of the electron transport chain.
The Luciferase Assay System, on the other hand, is used to measure the activity of the luciferase enzyme, which is commonly used as a reporter gene in gene expression studies.
Data analysis tools, such as GraphPad Prism, are often utilized in conjunction with enzyme assays to analyze the data and generate visualizations.
Automated laboratory equipment, like the Cobas 8000 and Immulite 2000, can also be employed to streamline the enzyme assay workflow and enhance throughput.
Overall, enzyme assays are a versatile and indispensable tool for researchers across various fields, from biochemistry and molecular biology to drug discovery and development.
By leveraging AI-driven insights and optimizing experimental protocols, researchers can enhance the reproducibility and accuracy of their enzyme assay-based studies, leading to more reliable and impactful findings.